
Home » Lupin Pushes Into Generic Opportunities in the U.S. Pharmaceutical Market
Lupin Pushes Into Generic Opportunities in the U.S. Pharmaceutical Market
The U.S. was a key contributor to the overall performance on the back of a strong flu season and the Tricor launch for pharma company Lupin, says Nomura Equity Research.
moneylife
moneylife
Upcoming Events
-
10Aug
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep